Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study-Reference-Cited by-同舟云学术

Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study

Published:2022-04-30 Issue: Volume: Page:e20220087
ISSN:1806-3756
Container-title:Jornal Brasileiro de Pneumologia
language:en
Short-container-title:J Bras Pneumol.

Author:

Battista Migliori1 Giovanni¹,Min Thong2, Pei²,Alffenaar3,4,5 Jan-Willem³,Denholm6,7 Justin⁴,Tadolini8,9 Marina⁵,Alyaquobi10 Fatma⁶,Al-Abri11 Seif⁷,Blanc12 François-Xavier⁸,Buonsenso13 Danilo⁹,Chakaya14,15 Jeremiah¹⁰,Cho4,16 Jin-Gun¹¹,Ruffo Codecasa17 Luigi¹²,Danila18 Edvardas¹³,Duarte19 Raquel¹⁴,Dukpa20 Rada¹⁵,García-García21 José-María¹⁶,Gualano22 Gina¹⁷,Kurhasani23,24 Xhevat¹⁸,Manika25 Katerina¹⁹,de Queiroz Mello26 Fernanda Carvalho²⁰,Pahl27 Kristin²¹,Rendon28 Adrian²²,Sotgiu29 Giovanni²³,Bassirou Souleymane30 Mahamadou²⁴,Thomas31 Tania A.²⁵,Tiberi32,33 Simon²⁶,Kunst32,33 Heinke²⁶,F. Udwadia34 Zarir²⁷,Goletti22 Delia¹⁷,Centis1 Rosella¹,D’Ambrosio35 Lia²⁸,Rossato Silva36 Denise²⁹

Affiliation:

1. 1. Istituti Clinici Scientifici Maugeri – IRCCS – Tradate, Italia.

2. 2. National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore.

3. 3. The University of Sydney, Pharmacy School, Sydney (NSW) Australia. 4. The University of Sidney at Westmead Hospital, Sydney (NSW) Australia. 5. Sydney Institute for Infectious Diseases, The University of Sydney, Sydney (NSW) Australia.

4. 6. Melbourne Health Victorian Tuberculosis Program, Melbourne (VIC) Australia. 7. Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne (VIC) Australia.

5. 8. Infectious Diseases Unit, Istituti Clinici Scientifici Maugeri – IRCCS – Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant’Orsola, Bologna, Italia. 9. Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.

6. 10. TB and Acute Respiratory Diseases Section, Department of Communicable Diseases, Directorate General of Disease Surveillance and Control, National TB Programme, MoH Oman, Muscat, Sultanate of Oman.

7. 11. Directorate General for Disease Surveillance and Control, MoH Oman, Muscat, Sultanate of Oman.

8. 12. Nantes Université, CHU Nantes, Service de Pneumologie, L’Institut du Thorax, Nantes, France.

9. 13. Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli – IRCCS – Roma, Italia.

10. 14. Department of Medicine, Dermatology and Therapeutics, Kenyatta University, Nairobi, Kenya. 15. Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

11. 4. The University of Sidney at Westmead Hospital, Sydney (NSW) Australia. 16. Parramatta Chest Clinic, Parramatta (NSW) Australia.

12. 17. TB Reference Centre of Villa Marelli Institute, Niguarda Hospital, Milano, Italia.

13. 18. Vilnius University Hospital Santaros Kilinkos, Vilinius, Lithuania.

14. 19. National Reference Centre for MDR-TB, Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal e Departamento de Ciências da Saúde Pública e Forenses, e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.

15. 20. National TB Control Program, Ministry of Health, Timbu, Bhutan.

16. 21. Programa Integrado de Investigación en Tuberculosis – PII-TB – Sociedad Española de Neumología y Cirugía Torácica – SEPAR – Barcelona, España.

17. 22. Istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani” – INMI – IRCCS, Roma, Italia.

18. 23. UBT – Higher Education Institution, Prishtina, Kosovo. 24. NGO KeA, Prishtina, Kosovo.

19. 25. Pulmonary Department, Aristotle University of Thessaloniki, “G. Papanikolaou” Hospital, Thessaloniki, Greece.

20. 26. Instituto de Doenças do Tórax, Faculdade de Medicina, Universidade Federal do Rio de Janeiro – UFRJ – Rio de Janeiro (RJ) Brasil.

21. 27. Clinton Health Access Initiative, Phnom Penh, Cambodia.

22. 28. Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias –CIPTIR – Hospital Universitario de Monterrey, Universidad Autónoma de Nuevo León, Monterrey, México.

23. 29. Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

24. 30. Damien Foundation, Niamey, Niger.

25. 31. Division of Infectious Diseases and International Health, University of Virginia, Charlottesville (VA) USA.

26. 32. Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. 33. Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom.

27. 34. P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India.

28. 35. Public Health Consulting Group, Lugano, Switzerland.

29. 36. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul – UFRGS– Porto Alegre, Brasil.

Abstract

The objective of this study was to describe country-specific lockdown measures and tuberculosis indicators collected during the first year of the COVID-19 pandemic. Data on lockdown/social restrictions (compulsory face masks and hand hygiene; international and local travel restrictions; restrictions to family visits, and school closures) were collected from 24 countries spanning five continents. The majority of the countries implemented multiple lockdowns with partial or full reopening. There was an overall decrease in active tuberculosis, drug-resistant tuberculosis, and latent tuberculosis cases. Although national lockdowns were effective in containing COVID-19 cases, several indicators of tuberculosis were affected during the pandemic.

Publisher

Sociedade Brasileira de Pneumologia e Tisiologia

Reference14 articles.

1. 1. Abu-Raya B, Migliori GB, O’Ryan M, Edwards K, Torres A, Alffenaar JW, et al. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Front Med (Lausanne). 2020;7:572485. https://doi.org/10.3389/fmed.2020.572485

2. 2. Migliori GB, Thong PM, Alffenaar JW, Denholm J, Tadolini M, Alyaquobi F, et al. Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study. Eur Respir J. 2021;58(5):2101786. https://doi.org/10.1183/13993003.01786-2021

3. 3. Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Álvarez-Navascués F, Assao-Neino MM, et al. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis. 2020;26(11):2709-2712. https://doi.org/10.3201/eid2611.203163

4. 4. Mauro V, Lorenzo M, Paolo C, Sergio H. Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases [published correction appears in Intern Emerg Med. 2021 Jan;16(1):249]. Intern Emerg Med. 2020;15(5):787-790. https://doi.org/10.1007/s11739-020-02395-z

5. 5. Silva DR, Müller AM, Tomasini Kda S, Dalcin Pde T, Golub JE, Conde MB. Active case finding of tuberculosis (TB) in an emergency room in a region with high prevalence of TB in Brazil. PLoS One. 2014;9(9):e107576. https://doi.org/10.1371/journal.pone.0107576

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of COVID-19 on diagnosis of tuberculosis and tuberculosis infection in South America, Asia, and Africa;Jornal Brasileiro de Pneumologia;2024-07-23

2. The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020–2023;PLOS Global Public Health;2024-07-03

3. Impact of COVID-19 Pandemic on Tuberculosis and Latent Tuberculosis Infection Diagnosis in Healthcare Workers;Journal of Occupational & Environmental Medicine;2024-04-25

4. When one door closes: a qualitative exploration of women’s experiences of access to sexual and reproductive health services during the COVID-19 lockdown in Nigeria;BMC Public Health;2024-04-23

5. The Global Impact of COVID-19 on Tuberculosis: A Thematic Scoping Review, 2020-2023;2024-03-06